In May 2026, the World Health Organisation (WHO) and the African Medicines Agency (AMA) signed a landmark Framework Agreement for Collaboration, establishing a structured partnership to strengthen regulatory systems, promote regulatory reliance and harmonisation, and improve access to safe, effective, and quality-assured health products across the continent. At the same time, the AMA continues to expand its operational role as more African Union Member States ratify the AMA Treaty,...

What's Changed? On 1 July 2026, Singapore's Health Sciences Authority (HSA) launched a stakeholder consultation on a proposed regulatory framework for Complementary Health Products (CHP) under the Health Products Act. The consultation is open from 1 July to 29 July 2026, inviting industry stakeholders and other interested parties to provide feedback on the proposed regulatory controls. The proposed framework covers a broad range of products, including health supplements, traditional medicines...

What's Changed? Malaysia's Medical Device Authority (MDA) has introduced a new Automated Re-Registration Route within the MeDC@St 2.0+ platform, marking an important step toward simplifying the renewal of medical device registrations. The MDA announced the new route on 10 July 2026, with the streamlined process becoming effective for eligible applications submitted from 13 July 2026. Applications submitted before this date continue to follow the normal evaluation route. The new pathway is...